Medici announced that as of July 10, 2026, shareholder Lin Changqing had reduced his holdings of the company's shares by a total of 240,000 shares through centralized bidding, accounting for 0.18% of the company's total share capital. After this change in equity, Lin Changqing's shareholding ratio fell from 2.50% to 2.32%, and his total shareholding ratio with co-actor Chen Guoxing fell from 6.13% to 5.95%, which is an integer multiple of 1%. As of the date of disclosure of the announcement, the holdings reduction plan has not yet been implemented. This change in equity does not affect the proposed acquisition, will not lead to changes in controlling shareholders or actual controllers, and does not involve disclosure of equity change reports.

Medici announced that as of July 10, 2026, shareholder Lin Changqing had reduced his holdings of the company's shares by a total of 240,000 shares through centralized bidding, accounting for 0.18% of the company's total share capital. After this change in equity, Lin Changqing's shareholding ratio fell from 2.50% to 2.32%, and his total shareholding ratio with co-actor Chen Guoxing fell from 6.13% to 5.95%, which is an integer multiple of 1%. As of the date of disclosure of the announcement, the holdings reduction plan has not yet been implemented. This change in equity does not affect the proposed acquisition, will not lead to changes in controlling shareholders or actual controllers, and does not involve disclosure of equity change reports.